Authors
Loading...
Laboratory study reveals B7-H1-mediated immune suppression in T-cell non-Hodgkin lymphoma, suggesting targeted inhibition as a potential therapeutic approach.
Wilcox et al. (2009) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: